RxSight, Inc.RxSight, Inc.RxSight, Inc.

RxSight, Inc.

No trades
See on Supercharts
Market capitalization
‪1.91 B‬USD
−1.42USD
‪−48.61 M‬USD
‪89.08 M‬USD
‪31.09 M‬
Beta (1Y)
1.93

About RxSight, Inc.

CEO
Ronald M. Kurtz
Headquarters
Aliso Viejo
Employees (FY)
374
Founded
1997
ISIN
US78349D1072
FIGI
BBG00THX1YN4
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RXST is 51.58 USD — it has decreased by 0.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange RxSight, Inc. stocks are traded under the ticker RXST.
RxSight, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
RXST stock is 4.46% volatile and has beta coefficient of 1.93. Check out the list of the most volatile stocks — is RxSight, Inc. there?
One year price forecast for RxSight, Inc. has a max estimate of 65.00 USD and a min estimate of 61.00 USD.
RXST earnings for the last quarter are −0.35 USD per share, whereas the estimation was −0.43 USD resulting in a 19.23% surprise. The estimated earnings for the next quarter are −0.38 USD per share. See more details about RxSight, Inc. earnings.
RxSight, Inc. revenue for the last quarter amounts to ‪22.20 M‬ USD despite the estimated figure of ‪20.55 M‬ USD. In the next quarter revenue is expected to reach ‪28.25 M‬ USD.
Yes, you can track RxSight, Inc. financials in yearly and quarterly reports right on TradingView.
RXST stock has fallen by 6.25% compared to the previous week, the month change is a 5.48% rise, over the last year RxSight, Inc. has showed a 196.44% increase.
RXST net income for the last quarter is ‪−9.18 M‬ USD, while the quarter before that showed ‪−12.42 M‬ USD of net income which accounts for 26.08% change. Track more RxSight, Inc. financial stats to get the full picture.
Today RxSight, Inc. has the market capitalization of ‪1.91 B‬, it has increased by 11.76% over the last week.
No, RXST doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RXST shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RxSight, Inc. stock right from TradingView charts — choose your broker and connect to your account.
RXST reached its all-time high on Mar 1, 2024 with the price of 58.21 USD, and its all-time low was 8.80 USD and was reached on Jan 7, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 21, 2024, the company has 374.00 employees. See our rating of the largest employees — is RxSight, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RxSight, Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RxSight, Inc. stock shows the buy signal. See more of RxSight, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on RxSight, Inc. future price: according to them, RXST price has a max estimate of 65.00 USD and a min estimate of 61.00 USD. Read a more detailed RxSight, Inc. forecast: see what analysts think of RxSight, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RxSight, Inc. EBITDA is ‪−45.84 M‬ USD, and current EBITDA margin is −51.46%. See more stats in RxSight, Inc. financial statements.